Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Genitourinary 1

Conditions

Multiple Myeloma 42Neoplasms, Plasma Cell 36Lymphoma, Non-Hodgkin 30Leukemia, Lymphocytic, Chronic, B-Cell 30Lymphoma 29Leukemia 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Lymphoma, Follicular 27Lymphoma, Large B-Cell, Diffuse 26Hodgkin Disease 26Lymphoma, Large-Cell, Immunoblastic 25Burkitt Lymphoma 25Lymphoma, Mantle-Cell 24Myelodysplastic Syndromes 23Lymphoma, B-Cell, Marginal Zone 23Leukemia, Myeloid, Acute 21Leukemia, Myeloid, Chronic-Phase 20Leukemia, Myeloid, Accelerated Phase 17Dendritic Cell Sarcoma, Interdigitating 17Recurrence 15Myeloproliferative Disorders 14Leukemia, Myelomonocytic, Chronic 14Blast Crisis 14Primary Myelofibrosis 13Congenital Abnormalities 13Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 10Graft vs Host Disease 10Myelodysplastic-Myeloproliferative Diseases 9Waldenstrom Macroglobulinemia 8Sezary Syndrome 8

Interventions

Dexamethasone 8Lenalidomide 4dexamethasone acetate 3dexamethasone 21-phosphate 3daratumumab 3auricularum 3Calcium Dobesilate 3Bortezomib 3pomalidomide 2ixazomib 2filanesib 2Steroids 2Radiotherapy 2Injections, Subcutaneous 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2silmitasertib 1navtemadlin; 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid 1milatuzumab 1cc-486 1carfilzomib 1Thalidomide 1Specimen Handling 1Sodium Selenite 1Radiation 1Proteasome Inhibitors 1Peripheral Blood Stem Cell Transplantation 1Panobinostat 1Melphalan 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Plasmacytoma × Radiotherapy × Plasma cell × Clear all
NCT04174196 2025-12-02

A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
21 enrolled
Plasma cell

Multiple Myeloma, Plasmacytoma

NCT02184533 2024-05-28

Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer

Stanford University

Phase 1 Completed
15 enrolled
GenitourinaryPlasma cell

Multiple Myeloma, Plasmacytoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡